Unique ID issued by UMIN | UMIN000039600 |
---|---|
Receipt number | R000045159 |
Scientific Title | APOLLO-Bio |
Date of disclosure of the study information | 2020/02/25 |
Last modified on | 2022/02/27 14:32:57 |
Exploratory biomarker study of APOLLO trial
APOLLO-Bio
APOLLO-Bio
APOLLO-Bio
Japan |
small cell lung cancer
Medicine in general | Hematology and clinical oncology |
Malignancy
YES
To explore biomarkers which may be involved with efficacy or safety of CBDCA/VP-16/atezolizumab therapy in patients with extended deisease small cell lung cancer
Others
Exploring biomarkers
Not applicable because this is an exploratory biomarker analysis
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1. Patients who participate APOLLO study and receive informed consent to this APOLLO-Bio study.
2. Patients who can submit enough specimen to be analyzed in this study.
None
200
1st name | Hiroaki, Yasuhiro |
Middle name | |
Last name | Akamatsu, Koh |
Wakayama Medical University
Internal Medicine III
641-8509
Wakayama
0734410619
h-akamat@wakayama-med.ac.jp
1st name | Daichi |
Middle name | Akamatsu |
Last name | Fujimoto |
Wakayama Medical University
Internal Medicine III
641-8509
Wakayama
0734410619
daichianzen@yahoo.co.jp
Wakayama Medical University
Chugai Pharmatheutical.co.ltd
Profit organization
Wakayama Medical University
811-1, kimiidera, Wakayama
0734410547
wa-rinri@wakayama-med.ac.jp
NO
2020 | Year | 02 | Month | 25 | Day |
Unpublished
137
No longer recruiting
2020 | Year | 02 | Month | 25 | Day |
2020 | Year | 02 | Month | 25 | Day |
2020 | Year | 02 | Month | 25 | Day |
2024 | Year | 01 | Month | 31 | Day |
Not applicable
2020 | Year | 02 | Month | 25 | Day |
2022 | Year | 02 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045159
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |